ZBTB40 antibody
Principal name
ZBTB40 antibody
Alternative names for ZBTB40 antibody
KIAA0478, Zinc finger and BTB domain-containing protein 40
SwissProt ID
Q9NUA8 (Human)
Gene ID
9923 (ZBTB40)
Ncbi ID
Available reactivities
Available hosts
Available applications
Western blot / Immunoblot (WB), Enzyme Immunoassay (E), Paraffin Sections (P), Immunocytochemistry/Immunofluorescence (ICC/IF)
Background of ZBTB40 antibody
- Kit Component:
- - KN214454G1, ZBTB40 gRNA vector 1 in pCas-Guide vector
- KN214454G2, ZBTB40 gRNA vector 2 in pCas-Guide vector
- KN214454D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
General readings
Filion GJP, Zhenilo S, Salozhin S, et al. A family of zinc finger proteins that bind methylated DNA and repress transcription. Mol. Cell. Biol. 2006; 26:169-81.
Human 721_B; WB Suggested Anti-ZBTB40 Antibody Titration: 0.2-1 ug/ml. ELISA Titer: 1:12500. Positive Control: 721_B cell lysate. ZBTB40 is strongly supported by BioGPS gene expression data to be expressed in Human 721_B cells.; ZBTB40 antibody - middle region (ARP34338_P050) in Human 721_B cells using Western Blot
Human Liver; WB Suggested Anti-ZBTB40 Antibody Titration: 0.2-1 ug/ml. ELISA Titer: 1:12500. Positive Control: Human Liver; ZBTB40 antibody - middle region (ARP39150_P050) in Human Liver cells using Western Blot
Human HeLa; WB Suggested Anti-ZBTB40 Antibody. . Titration: 1.0 ug/ml. . Positive Control: Hela Whole Cell. ZBTB40 is strongly supported by BioGPS gene expression data to be expressed in Human HeLa cells.; ZBTB40 antibody - N-terminal region (ARP34337_P050) in Human HeLa cells using Western Blot
Western blot analysis of ZBTB40 in Raji cell lysate with ZBTB40 antibody Cat.-No. AP55412PU-N at 0.5 µg/ml in (A) the absence and (B) the presence of blocking peptide Cat.-No. AP55412CP-N.
Western blot analysis of extracts from 293 cells, using ZBTB40 antibody.The lane on the right is treated with the synthesized peptide.
Immunohistochemistry analysis of paraffin-embedded human lung carcinoma tissue, using ZBTB40 antibody.The picture on the right is treated with the synthesized peptide.
Western blot analysis of ZBTB40 in Raji cell lysate with ZBTB40 antibody at 0.5 ug/ml in (A) the absence and (B) the presence of blocking peptide.
Immunofluorescence of ZBTB40 in Raji cells with ZBTB40 antibody at 20 ug/mL.
WB Suggested Anti-ZBTB40 Antibody Titration: 0.2-1 ug/ml; ELISA Titer: 1:12500; Positive Control: 721_B cell lysate ZBTB40 is strongly supported by BioGPS gene expression data to be expressed in Human 721_B cells
Primärantikörper
| Katalog-Nr. | Wirt | Iso. | Klon | Präs. | Reakt. | Anwendungen | |
|---|---|---|---|---|---|---|---|
| TA314990 | ZBTB40 Antikörper |
||||||
| Rabbit polyclonal anti-ZBTB40 antibody | |||||||
 |
Rabbit | IgG | Purified | Hu, Ms | E, P, WB |
0.1 ml /
335,00 €
|
|
| OriGene Technologies, Inc. | |||||||
 +1 weiteres Bild |
|||||||
| TA319800 | ZBTB40 (N-term) Antikörper |
||||||
| Rabbit Polyclonal ZBTB40 Antibody | |||||||
 |
Rabbit | IgG | Aff - Purified | Hu | E, ICC/IF, WB |
0.1 mg /
415,00 €
|
|
| OriGene Technologies, Inc. | |||||||
| +1 weiteres Bild |
|||||||
| TA335610 | ZBTB40 Antikörper |
||||||
| Rabbit Polyclonal Anti-ZBTB40 Antibody | |||||||
 |
Rabbit | IgG | Purified | Bov, Can, Eq, GP, Hu, Ms, Rt | WB |
50 µg /
360,00 €
|
|
| OriGene Technologies, Inc. | |||||||
| TA343759 | ZBTB40 Antikörper |
||||||
| Rabbit Polyclonal Anti-ZBTB40 Antibody | |||||||
 |
Rabbit | IgG | Purified | Bov, Can, Eq, GP, Hu, Ms, Rt | WB |
50 µg /
360,00 €
|
|
| OriGene Technologies, Inc. | |||||||
Human Lenti ORF Particles
| Katalog-Nr. | ||
|---|---|---|
| RC214454L2V | Lenti ORF particles, ZBTB40 (mGFP-tagged) - Human zinc finger and BTB domain containing 40 (ZBTB40), transcript variant 1, 200 uL, >10^7 TU/mL |
|
|
200 µl /
2.570,00 €
|
|
| OriGene Technologies, Inc. | ||
| RC214454L1V | Lenti ORF particles, ZBTB40 (Myc-DDK tagged) - Human zinc finger and BTB domain containing 40 (ZBTB40), transcript variant 1 , 200 uL, >10^7 TU/mL |
|
|
200 µl /
2.310,00 €
|
|
| OriGene Technologies, Inc. | ||
